Bolus control for contrast imaging with 3D

• US 20050234340A1
• Filed: 03/28/2005
• Published: 10/20/2005
• Est. Priority Date: 03/31/2004
• Status: Abandoned Application

• Current Assignee: Koninklijke Philips Electronics N.V. (Koninklijke Philips N.V.)
• Original Assignee: Koninklijke Philips Electronics N.V. (Koninklijke Philips N.V.)
• Inventors: Frisa, Janice L., Poland, McKee D., Brock-Fisher, George A.
• Application Number:
  US11/091,635
• Publication Number:
  US 20050234340A1
• Time in Patent Office: Days
• US Class Current: 600/458
• CPC Class Codes: A61B 8/065 to determine blood output from the heart in general A61B5/029
• CPC Class Codes: A61B 8/481 involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream analysis of echo signal exploiting properties of a contrast enhancer in devices for short-range imaging with acoustic waves G01S7/52039
• CPC Class Codes: A61B 8/483 involving the acquisition of a 3D volume of data
• CPC Class Codes: G01S 15/8993 Three dimensional imaging systems
• CPC Class Codes: G01S 7/52041 detecting modification of a contrast enhancer, e.g. detecting the destruction of a contrast agent by an acoustic wave, e.g. loss of correlation diagnostic techniques involving the use of contrast agents A61B8/481
• CPC Class Codes: G01S 7/52074 Composite displays, e.g. split-screen displays; Combination of multiple images or of images and alphanumeric tabular information
• CPC Class Codes: G01S 7/52085 Details related to the ultrasound signal acquisition, e.g. scan sequences control of medical diagnostic ultrasound devices A61B8/54

Abstract

The present invention relates to contrast imaging. More particularly, the present invention relates to apparatus and methods for ultrasound contrast imaging in which a high-MI signal destroys contrast agent in a blood supply region of the heart after previously infused thoroughly with contrast agent enhanced blood, and a portion of the heart other than the blood supply region is imaged with low MI ultrasound to track the decrease in contrast agent containing blood due to perfusion into the “other then the blood supply region” by blood from the blood supply region, as a function of time.

Claims

1. A method of perfusion analysis using ultrasound contrast agents, comprising the steps of:

introducing contrast agent into the bloodstream of a patient under examination in order to perfuse a volume of interest;

identifying the volume of interest and a destruction volume, proximate the volume of interest, which supplies blood to the volume of interest, by scanning the volume of interest and destruction volume using low mechanical index (MI);

destroying at least the contrast agent in the blood supply within the destruction volume using high MI ultrasound in order to destroy contrast agent within blood present in the destruction volume such that said present blood is contrast-agent-depleted, which destruction volume includes the blood supply; and

imaging the volume of interest using low MI ultrasound substantially simultaneously as the contrast-agent-depleted blood from the destruction volume perfuses the volume of interest, causing an exchange within the volume of interest, of contrast-agent-laden blood with contrast-agent-depleted blood.

2. The method set forth in claim 1, wherein the step of imaging includes quantifying blood volumes present in the volume of interest.

3. The method set forth in claim 1, wherein the step of imaging includes quantifying velocity of blood flowing within the volume of interest.

4. The method as set forth in claim 1, wherein the step of identifying further includes identifying the destruction volume to include tissue, proximate the volume of interest, from which destruction volume contrast-agent-laden blood located in the tissue could move into the volume of interest during the step of imaging, and destroying same in said destruction volume to prevent the blood from seeping into the volume of interest.

5. The method as set forth in claim 1, where blood flow within the volume of interest is a cardiac volume.

6. The method as set forth in claim 1, wherein the step of imaging includes identifying restricted blood flow within the volume of interest.

7. The method as set forth in claim 1, wherein the step of identifying includes defining volumetric parameters which define the volume of interest using a biplane scan process.

8. The method as set forth in claim 7, wherein the volumetric parameters include the location of each biplane.

9. The method as set forth in claim 8, wherein the volume of interest is bounded by each plane of the biplane.

10. The method as set forth in claim 1, wherein the step of identifying is user adjustable.

11. The method as set forth in claim 3, wherein said velocity information is displayed.

12. The method as set forth in claim 11, wherein said velocity information is displayed as a color image, and velocity information is color-coded.

13. The method of claim 1, where the destruction region is defined by a c-scan plane, and the ROI is contained within the biplane.

14. A computer readable medium within which is encoded a set of computer instructions, which set provides for the implementation of the method as set forth in claim 1.

40. The method set forth in claim 1, wherein said steps of destroying and imaging are implemented on one of a frame interleave and a line interleave basis.

15. A method for conducting ultrasound perfusion studies on myocardial tissues utilizing ultrasound contrast agents, comprising the steps of:

infusing a patient'"'"'s blood with contrast agent;

transmitting low-MI ultrasound pulses into a region of interest (ROI) within the patient'"'"'s heart, and receiving ultrasound echoes of the pulses, to highlight the presence of blood infused with the contrast agent in myocardial tissues disposed in the ROI;

determining an imaging volume within the ROI, from which it is desired to quantify perfusion data for the imaging volume;

determining a destruction volume within the ROI, proximate the imaging volume, which destruction volume is determined to include substantially any blood, which might perfuse the imaging volume in the region;

transmitting high-MI ultrasound pulses to the destruction volume to destroy all contrast agent present therein, and substantially simultaneously imaging the imaging volume using low-MI ultrasound pulses; and

calculating perfusion data for the imaging volume based on an assessment of a rate of decrease of a volume of contrast-agent-laden blood therein as the contrast-agent-depleted blood perfuses the imaging volume.

16. The method as set forth in claim 15, wherein the step of calculating is assumed to be accurate in accordance with a detection of a reperfusion, with contrast-agent-laden blood, of the destruction volume subsequent to cessation of the imaging therein with high MI ultrasound.

17. The method as set forth in claim 15, wherein the step of determining further includes identifying a destruction volume through which contrast-agent-laden blood flows into the imaging volume.

18. The method as set forth in claim 17, further including imaging said destruction volume to prevent contrast-agent-laden blood from moving into the imaging volume.

19. The method as set forth in claim 15, wherein said region is identified using a biplane scan process which produces a small c-scan relative the location of said biplanes.

20. The method as set forth in claim 17, wherein said destruction volume is defined by one of said biplanes.

21. The method as set forth in claim 19, wherein said C-scan includes the imaging volume.

41. The method set forth in claim 15, wherein said step of transmitting includes frame interleaving said high and low MI frames.

22. A ultrasound imaging system for conducting perfusion analysis of myocardial tissue volumes utilizing ultrasound contrast agents, comprising:

an ultrasound transducer for transmitting low-MI ultrasound pulses into a region of a patient'"'"'s heart, and receiving ultrasound echoes of the pulses, to highlight the presence of blood infused with the contrast agent in the region; and

a selector within a user interface to the ultrasound system for allowing a user;

1) to choose an imaging volume in the region,

2) to choose a destruction volume within the region, wherein the destruction volume is a volume in th region proximate the imaging volume through which contrast-agent-laden blood perfuses the imaging volume,

3) to automatically scan the destruction volume with high MI ultrasound to destroy contrast agent in blood present therein, and

4) to automatically scan the imaging volume with low MI ultrasound;

wherein said automatic scan of said imaging volume is conducted substantially immediately at completion of said automatic scanning of the destruction volume to detect a perfusion of non-contrast-agent-laden blood thereinto.

23. The imaging system set forth in claim 22, wherein the selector allows the user to implement a biplane with small c-scan volume mode of imaging, by which the user selects whether the c-scan is the destruction volume or the imaging volume.

24. The imaging system set forth in claim 22, wherein the selector allows the user to select a size and location of one of the imaging volume and destruction volume.

25. The imaging system set forth in claim 22, wherein the selector allows the user to select the MI implemented in any transmission of ultrasound.

42. The imaging system as set forth in claim 22, wherein said selector automatically scans the destruction and imaging volumes on a frame interleaved basis.

43. The imaging system as set forth in claim 22, wherein the transducer is a TEE probe comprising a 2D array.

44. The imaging system as set forth in claim 43, wherein the transducer is a TEE probe comprising a matrix array.

26. A ultrasound imaging system for conducting perfusion analysis of myocardial tissue volumes utilizing ultrasound contrast agents, comprising:

an ultrasound transducer for transmitting low-MI ultrasound pulses into a region of a patient'"'"'s heart, and receiving ultrasound echoes of the pulses, to highlight the presence of blood infused with the contrast agent in the region; and

a selector within a user interface to the ultrasound system for allowing a user;

5) to choose an imaging volume in the region,

6) to choose a destruction volume within the region, wherein the destruction volume is a volume in th region proximate the imaging volume through which contrast-agent-laden blood perfuses the imaging volume,

7) to automatically scan the destruction volume with high MI ultrasound to destroy contrast agent in blood present therein, and

8) to automatically scan the imaging volume with low MI ultrasound;

wherein said automatic scan of said imaging volume is conducted substantially immediately at completion of said automatic scanning of the destruction volume and includes scanning at least two intersecting planes and a related volume to detect a perfusion of non-contrast-agent-laden blood thereinto.

27. The ultrasound imaging system of claim 26, wherein the related volume is a reference volume whose center tracks the intersection of one of the at least 2 intersecting planes.

28. The ultrasound imaging system of claim 27, wherein the system extracts a C-scan developed from the reference volume and displays it simultaneously with multi-plane images corresponding to the at least 2 intersecting planes.

29. The ultrasound imaging system of claim 26, further including a user interface (UI) which provides one of a cursor dot, diamond or like indicator on at least one displayed plane of the two intersecting planes, which indicator at least one of:

controls the tilt of the another plane, and indicates the tilt of another plane, and further indicates/controls the depth of the C-scan displayed alongside the multi-plane images.

30. The ultrasound imaging system of claim 28, further including an I-scan instead of a C-scan, with user control over the incline angle and direction.

31. The ultrasound imaging system of claim 27, wherein the center of the reference volume is offset from the line of intersection by an amount and in a direction controlled by the user interface.

32. The ultrasound imaging system of claim 28, wherein a spatial extent and a scan line density are configured by the user, trading off image quality, frame rate, and viewing extent.

33. The ultrasound imaging system of claim 28, wherein the reference volume acquires Color Flow scan lines and/or black and white, and the C-scan displays Flow.

34. The ultrasound imaging system of claim 33, wherein the reference volume has scan line transmit/receive parameters selected for visualizing contrast agent and/or releasing pharmaceuticals.

35. The ultrasound imaging system of claim 26, wherein the automatic scanning generates a c-scan using AQ, to determine a real-time valve volume, with on-screen border indication and volume measurement output.

36. The ultrasound imaging system as set forth in claim 35, wherein real-time-color flow may be implemented over the real-time valve volume.

37. The ultrasound imaging system of claim 35, wherein the user may be provided with real-time image information defining a flow value, which flow value represents the integral of the flow from the real-time valve volume.

38. The ultrasound imaging system of claim 37, wherein said real-time image information includes a graph of the flow value over time.

39. The ultrasound imaging system of claim 38, further including that the user interface include a mechanism for varying a look angle relative the valve area to maximize flow detection.